What are the key questions to ask when evaluating a patient for Ankylosing Spondylitis (AS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When evaluating a patient for Ankylosing Spondylitis (AS), it is crucial to ask about chronic low back pain lasting more than 3 months that improves with activity and worsens with rest, especially pain that awakens patients at night, as this is a hallmark feature of the disease 1. The key questions to ask include:

  • Morning stiffness lasting more than 30 minutes
  • Age of symptom onset (typically before age 45)
  • Response to NSAIDs (often dramatic improvement)
  • Family history of ankylosing spondylitis or other spondyloarthropathies
  • Associated symptoms like uveitis, psoriasis, inflammatory bowel disease, or peripheral arthritis
  • Systemic symptoms such as fatigue, weight loss, or fever
  • Functional limitations in daily activities and posture changes These questions are essential because ankylosing spondylitis has an insidious onset with inflammatory back pain as its hallmark feature, and early diagnosis is critical to prevent disease progression and improve quality of life 1. The disease typically affects the sacroiliac joints and spine, causing progressive fusion if untreated, and physical examination findings like limited spinal mobility and sacroiliac joint tenderness, along with elevated inflammatory markers and HLA-B27 testing, will complement the history to establish the diagnosis 1. It is also important to consider the patient's individual characteristics, including comorbidities and psychosocial factors, when evaluating and managing AS, as treatment should be individualized according to the current signs and symptoms of the disease and the patient's characteristics 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.